1. Home
  2. MRNA vs SWK Comparison

MRNA vs SWK Comparison

Compare MRNA & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • SWK
  • Stock Information
  • Founded
  • MRNA 2010
  • SWK 1843
  • Country
  • MRNA United States
  • SWK United States
  • Employees
  • MRNA N/A
  • SWK N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • SWK Industrial Machinery/Components
  • Sector
  • MRNA Health Care
  • SWK Consumer Discretionary
  • Exchange
  • MRNA Nasdaq
  • SWK Nasdaq
  • Market Cap
  • MRNA 9.2B
  • SWK 10.5B
  • IPO Year
  • MRNA 2018
  • SWK N/A
  • Fundamental
  • Price
  • MRNA $26.33
  • SWK $67.84
  • Analyst Decision
  • MRNA Hold
  • SWK Buy
  • Analyst Count
  • MRNA 15
  • SWK 9
  • Target Price
  • MRNA $36.69
  • SWK $92.25
  • AVG Volume (30 Days)
  • MRNA 12.0M
  • SWK 2.0M
  • Earning Date
  • MRNA 11-06-2025
  • SWK 11-04-2025
  • Dividend Yield
  • MRNA N/A
  • SWK 4.91%
  • EPS Growth
  • MRNA N/A
  • SWK N/A
  • EPS
  • MRNA N/A
  • SWK 2.90
  • Revenue
  • MRNA $2,232,000,000.00
  • SWK $15,166,300,000.00
  • Revenue This Year
  • MRNA N/A
  • SWK $0.46
  • Revenue Next Year
  • MRNA $10.38
  • SWK $3.65
  • P/E Ratio
  • MRNA N/A
  • SWK $23.34
  • Revenue Growth
  • MRNA N/A
  • SWK N/A
  • 52 Week Low
  • MRNA $23.04
  • SWK $53.91
  • 52 Week High
  • MRNA $48.92
  • SWK $93.63
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 53.21
  • SWK 44.39
  • Support Level
  • MRNA $23.04
  • SWK $66.50
  • Resistance Level
  • MRNA $25.56
  • SWK $68.98
  • Average True Range (ATR)
  • MRNA 1.58
  • SWK 2.42
  • MACD
  • MRNA -0.07
  • SWK 0.04
  • Stochastic Oscillator
  • MRNA 57.39
  • SWK 31.87

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About SWK Stanley Black & Decker Inc.

Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.

Share on Social Networks: